Institutional Repository of Vilnius University
Homologinės rekombinacinės reparacijos (HRR) genų neaiškios reikšmės variantų analizė krūties vėžiu sergančių asmenų genominėje DNR /
Abstract
dc:descriptionBreast cancer is the most common oncological disease in women. About 5–10 % of breast cancer cases are associated with a genetically inherited predisposition to malignancy. The results of genetic tests are important for the proband's treatment selection and prognosis for his 1st and 2nd degree relatives. In the last decade, molecular oncogenetic diagnostics are mainly carried out by NGS technology, which identifies changes in the DNA sequence and divides them into benign, likely benign, uncertain, likely pathogenic, and pathogenic. Evaluation of variants of unknown significance is the greatest challenge of geneticists, therefore analysis of gene variants of uncertain significance (VUS) and assessment of impact on cancer pathogenesis are very important in the clinical context. The aim of this work is to evaluate the possible influence of the identified HRR gene variants of uncertain significance on the pathogenesis of breast cancer after the analysis of NGS data. The research begins by creating selection criteria for selecting a group of subjects that meet the defined work object; after analysing the results of the NGS, forming a group of subjects corresponding to the defined work object; performing the analysis of identified HRR gene variants of uncertain significance and evaluating their likely clinical significance, based on the criteria established by ACMG and AMP as well as calculating the values of each studied variant in value points according to the standardized system; summarizing the possible influence of the studied HRR gene variants on the analysed phenotype. The research methodology is based on the analysis and interpretation of the data of 210 individuals diagnosed with breast cancer and no pathogenic or potentially pathogenic mutations in the HRR genes, performed with the Ion TorrentTM technology, according to the guidelines for the analysis of the results. The results of the study showed that of the 37 different variants identified in 14 HRR genes, 10 variants retained the status of VUS; 1 variant was assessed as VUS, but suggesting benign; 21 variant was assessed as VUS, but suggesting pathogenic; 6 variants were assigned to the group of likely pathogenic variants. To confirm the results obtained in this study, more detailed studies are needed.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Balsytė, Andrėja,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD192843586&prefLang=en_US